• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Latest News

Image credit: zimmytws | stock.adobe.com
Is There a Correlation Between Medical Debt and Delayed Mental Health Care in the United States?

July 19th 2024

JAMA study aims to determine whether financial barriers impact access to mental health services.

Stock.adobe.com
South Korean Company Announces Development of Oral GLP-1 Treatment

July 19th 2024

stock.adobe.com
Genomics plc Extends Partnership with Vertex Pharmaceuticals

July 19th 2024

FDA Approves Voquezna for GERD Treatment
FDA Approves Voquezna for GERD Treatment

July 19th 2024

Mark Cuban Talks Drug Pricing: Pharm Exec Exclusive

Now more than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur discusses the prescription drug cost landscape and shares his recipe for true disruption to the pharma pricing machine.

Now more than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur discusses the prescription drug cost landscape and shares his recipe for true disruption to the pharma pricing machine.

Conference Coverage

View All
Sarclisa Combination Improves Progression-Free Survival in Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma
Sarclisa Combination Improves Progression-Free Survival in Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma

June 4th 2024

Moderna, Merck Present Promising Trial Data for a Combination of V940 with Keytruda for the Treatment of High-Risk Melanoma Following Complete Resection
Moderna, Merck Present Promising Trial Data for a Combination of V940 with Keytruda for the Treatment of High-Risk Melanoma Following Complete Resection

June 4th 2024

Phase III Trial Data Presented at ASCO Show Imfinzi Improves Survival in Limited-Stage Small Cell Lung Cancer
Phase III Trial Data Presented at ASCO Show Imfinzi Improves Survival in Limited-Stage Small Cell Lung Cancer

June 3rd 2024

Data Presented at ASCO Show Improved Complete Response with Jemperli as a First-Line Treatment for Locally Advanced Rectal Cancer in Patients with Mismatch Repair Deficient Status
Data Presented at ASCO Show Improved Complete Response with Jemperli as a First-Line Treatment for Locally Advanced Rectal Cancer in Patients with Mismatch Repair Deficient Status

June 3rd 2024

Latest Videos
Podcasts

All News